Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Tian M, Wei JS, Shivaprasad N, Highfill SL, Gryder BE, Milewski D, Brown GT, Moses L, Song H, Wu JT, Azorsa P, Kumar J, Schneider D, Chou HC, Song YK, Rahmy A, Masih KE, Kim YY, Belyea B, Linardic CM, Dropulic B, Sullivan PM, Sorensen PH, Dimitrov DS, Maris JM, Mackall CL, Orentas RJ, Cheuk AT, Khan J. Tian M, et al. Among authors: orentas rj. Cell Rep Med. 2023 Oct 17;4(10):101212. doi: 10.1016/j.xcrm.2023.101212. Epub 2023 Sep 28. Cell Rep Med. 2023. PMID: 37774704 Free PMC article.
Place-of-care manufacturing of gene therapies.
Adair JE, Anthony-Gonda K, Bayigga L, Orentas R, Mutuluuza CK, Mathews V, Dropulić B. Adair JE, et al. Lancet Haematol. 2022 Nov;9(11):e807-e808. doi: 10.1016/S2352-3026(22)00327-1. Lancet Haematol. 2022. PMID: 36328038 No abstract available.
In vivo killing of primary HIV-infected cells by peripheral-injected early memory-enriched anti-HIV duoCAR T cells.
Anthony-Gonda K, Ray A, Su H, Wang Y, Xiong Y, Lee D, Block A, Chilunda V, Weiselberg J, Zemelko L, Wang YY, Kleinsorge-Block S, Reese JS, de Lima M, Ochsenbauer C, Kappes JC, Dimitrov DS, Orentas R, Deeks SG, Rutishauser RL, Berman JW, Goldstein H, Dropulić B. Anthony-Gonda K, et al. JCI Insight. 2022 Nov 8;7(21):e161698. doi: 10.1172/jci.insight.161698. JCI Insight. 2022. PMID: 36345941 Free PMC article.
Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma.
Tian M, Wei JS, Shivaprasad N, Highfill SL, Gryder BE, Milewski D, Brown GT, Moses L, Song H, Wu JT, Azorsa P, Kumar J, Schneider D, Chou HC, Song YK, Rahmy A, Masih KE, Kim YY, Belyea B, Linardic CM, Dropulic B, Sullivan PM, Sorensen PH, Dimitrov DS, Maris JM, Mackall CL, Orentas RJ, Cheuk AT, Khan J. Tian M, et al. Among authors: orentas rj. Cell Rep Med. 2024 May 21;5(5):101586. doi: 10.1016/j.xcrm.2024.101586. Epub 2024 May 9. Cell Rep Med. 2024. PMID: 38723625 Free PMC article. No abstract available.
A positive take on negative selection for CAR-T manufacturing.
Orentas RJ. Orentas RJ. Mol Ther Methods Clin Dev. 2024 Mar 1;32(1):101218. doi: 10.1016/j.omtm.2024.101218. eCollection 2024 Mar 14. Mol Ther Methods Clin Dev. 2024. PMID: 38445044 Free PMC article. No abstract available.
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.
Pinto N, Albert CM, Taylor MR, Ullom HB, Wilson AL, Huang W, Wendler J, Pattabhi S, Seidel K, Brown C, Gustafson JA, Rawlings-Rhea SD, Cheeney SHE, Burleigh K, Gustafson HH, Orentas RJ, Vitanza NA, Gardner RA, Jensen MC, Park JR. Pinto N, et al. Among authors: orentas rj. J Clin Oncol. 2024 Dec 10;42(35):4163-4172. doi: 10.1200/JCO.23.02229. Epub 2024 Sep 10. J Clin Oncol. 2024. PMID: 39255444 Clinical Trial.
Generation of Anti-HIV CAR-T Cells for Preclinical Research.
Su H, Anthony-Gonda K, Orentas RJ, Dropulić B, Goldstein H. Su H, et al. Among authors: orentas rj. Methods Mol Biol. 2024;2807:287-298. doi: 10.1007/978-1-0716-3862-0_20. Methods Mol Biol. 2024. PMID: 38743236
77 results